Healthcare · Medical - Care Facilities
Price
$155.57
Market Cap
$9.7B
Employees
101,500
Beta
1.08
Avg Volume
1,021,714
CEO
Marc D. Miller
Universal Health Services, Inc. (UHS), operating through its various divisions, is a healthcare entity that both owns and manages a network of acute care hospitals, along with outpatient and specialized behavioral health treatment centers. Its business operations are strategically bifurcated into two main segments: Acute Care Hospital Services and Behavioral Health Care Services. The hospitals under its management provide a comprehensive spectrum of medical provisions, encompassing general and specialty surgical interventions, internal medicine, obstetrics, urgent and emergency department services, diagnostic imaging (radiology), cancer therapy (oncology), advanced diagnostic procedures, cardiac care, pediatric medicine, pharmaceutical services, and mental health support. As of a reported date of February 24, 2022, the company's significant presence included the ownership or operation of 363 inpatient facilities, complemented by 40 outpatient and other specialized sites. These facilities are distributed across 39 U.S. states, the District of Columbia, the United Kingdom, and Puerto Rico. Beyond direct patient care, UHS also extends into commercial health insurance provision and offers a variety of crucial management support functions. These include centralized procurement, information technology infrastructure, financial oversight and control mechanisms, strategic facilities planning, physician talent acquisition, administrative staff management, marketing initiatives, and public relations efforts. Universal Health Services, Inc. was established in 1978 and maintains its principal executive offices in King of Prussia, Pennsylvania.
Runs with full report
Price Overview
Last updated: Jul 11, 2026 4:43am (just now)
Current data · timestamped when a report runs
$155.57
Change · Jul 11
+0.37 (+0.24%)
Day Range
$153.11 – $156.01
52-Week Range
$140.08 – $246.33
50-Day MA
$155.29
200-Day MA
$195.44
Volume
431,273.00
Analyst Price Targets
Low
$165.00
Consensus
$207.57
High
$310.00
(52 analysts)
Share Structure
Outstanding
62,606,336.00
Float
50,389,607.00
Free Float
80.5%
High free float
— 80.5% of shares trade freely, ~19.5% held by insiders/institutions
Very liquid — most shares trade freely. Low insider ownership can mean less management alignment, but makes large position sizing straightforward.
Price History (1 Year)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
API Direct from provider
CALC Derived from statements
P/E Ratio (Price per dollar of earnings)
APIStock Price / EPS (Diluted)
6.25
Stock Price: $155.57
EPS (Diluted): 23.42
EPS (Diluted): 23.42
P/B Ratio (Price vs net asset value)
APIStock Price / Book Value Per Share
1.91
Stock Price: $155.57
Total Equity: $7.28B
Shares: 64,462,000
Total Equity: $7.28B
Shares: 64,462,000
EV/EBITDA (Total value vs operating profit)
APIEnterprise Value / EBITDA
5.27
Market Cap: $9.74B
Total Debt: $5.08B
Cash: $137.80M
EBITDA: $2.74B
Total Debt: $5.08B
Cash: $137.80M
EBITDA: $2.74B
Enterprise Value (Takeover price (cap + debt - cash))
APIMarket Cap + Total Debt - Cash
$19.2B
Market Cap: $9.74B
Total Debt: $5.08B
Cash: $137.80M
Total Debt: $5.08B
Cash: $137.80M
Gross Margin (Revenue left after direct costs)
APIGross Profit / Revenue
90.4%
Gross Profit: $15.71B
Revenue: $17.36B
Revenue: $17.36B
Operating Margin (Revenue left after all operations)
APIOperating Income / Revenue
11.5%
Operating Income: $1.99B
Revenue: $17.36B
Revenue: $17.36B
Net Margin (Revenue left as actual profit)
APINet Income / Revenue
8.6%
Net Income: $1.49B
Revenue: $17.36B
Revenue: $17.36B
ROE (Profit from shareholder equity)
APINet Income / Total Equity
20.9%
Net Income: $1.49B
Total Equity: $7.28B
Total Equity: $7.28B
ROIC (Profit from all invested capital)
APINOPAT / Invested Capital
11.8%
Operating Income: $1.99B
Tax Rate: 23.4%
Equity: $7.28B
Total Debt: $5.08B
Cash: $137.80M
Tax Rate: 23.4%
Equity: $7.28B
Total Debt: $5.08B
Cash: $137.80M
Current Ratio (Can it pay short-term bills)
APICurrent Assets / Current Liabilities
1.05
Current Assets: $3.41B
Current Liabilities: $3.24B
Current Liabilities: $3.24B
Debt/Equity (Leverage — debt vs equity)
CALCTotal Debt / Total Equity
0.70
Short-Term Debt: $821.40M
Long-Term Debt: $4.26B
Total Debt: $5.08B
Total Equity: $7.28B
Long-Term Debt: $4.26B
Total Debt: $5.08B
Total Equity: $7.28B
Rev/Share (Top-line per share)
CALCRevenue / Shares Outstanding
$269.38
Revenue: $17.36B
Shares: 64,462,000
Shares: 64,462,000
Book Value/Share (Net assets per share)
CALC(Total Assets - Total Liabilities) / Shares
$112.87
Total Equity: $7.28B
Shares: 64,462,000
Shares: 64,462,000
FCF/Share (Real cash generated per share)
CALC(Operating Cash Flow + CapEx) / Shares
$13.17
Operating CF: $1.86B
CapEx: -$1.02B
Shares: 64,462,000
CapEx: -$1.02B
Shares: 64,462,000
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
APILast Annual Dividend / Stock Price
0.4%
Last Dividend: N/A
Stock Price: $155.57
Stock Price: $155.57
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
—
Dividends Paid: N/A
Net Income: $1.49B
Net Income: $1.49B
Dividends paid not available in cash flow statement
Industry Benchmarks
Compares UHS against LLM-researched typical ranges for its
industry. One research call per industry, cached indefinitely — every stock in the same industry
reuses the same baseline.
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
0
Company Classification
— What type of company is this?
1
Industry Landscape
— Where is the industry headed?
2
Company Momentum
— Where is this company trending?
3
Forward Projection
— 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a
DCF Valuation
— Present value of future cash flows
4b
Earnings Power Value
— Floor value — worth with zero growth
4c
Anchored PE
— Industry PE adjusted for growth differential
4d
Reverse DCF
— What growth is the market pricing in?
4e
Revenue-Based DCF
— For growth/narrative companies (skip if mature earner)
4f
Anchored P/S
— Price-to-Sales peer comparison (skip if mature earner)
4g
Scenario Analysis
— Bull / Base / Bear (skip if mature earner)
4h
Dividend Discount Model
— For dividend/income stocks only
4i
Book Value Analysis
— For deep value / turnaround stocks only
4j
Insider Activity
— Are insiders buying or selling?
4f
Cash Flow Quality
— How trustworthy is the FCF?
4g
Debt Maturity Risk
— Can it handle its debt?
4h
Macro Environment
— Rates, market valuation, volatility
4i
Sector Intelligence
— How does this company compare within its sector?
4j
Revenue Confidence
— How reliable is the growth projection?
4k
Sensitivity Analysis
— How fragile is the fair value estimate?
4l
Sector Demand Cycle
— Is the sector in a boom, steady state, or contraction?
5
AI Investigation
— Adaptive research engine (Claude)
5b
Thesis Evaluation
— What does the market believe? (narrative/platform stocks only)
6
Valuation Synthesis
— Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
Last updated: Jul 11, 2026 4:43am (just now)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $12.6B | $13.4B | $14.3B | $15.8B | $17.4B |
| Cost of Revenue | $1.4B | $1.5B | $1.5B | $1.6B | $1.7B |
| Gross Profit | $11.2B | $11.9B | $12.7B | $14.2B | $15.7B |
| Operating Expenses | $9.9B | $10.9B | $11.6B | $12.6B | $13.7B |
| Operating Income | $1.4B | $1.0B | $1.2B | $1.7B | $2.0B |
| Net Income | $991.6M | $675.6M | $717.8M | $1.1B | $1.5B |
| EBITDA | $1.9B | $1.6B | $1.7B | $2.3B | $2.7B |
| EPS | $11.99 | $9.23 | $10.35 | $17.16 | $23.42 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
Last updated: Jul 11, 2026 4:43am (just now)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $115.3M | $102.8M | $119.4M | $126.0M | $137.8M |
| Total Current Assets | $2.3B | $2.5B | $2.8B | $2.8B | $3.4B |
| Total Assets | $13.1B | $13.5B | $14.0B | $14.5B | $16.0B |
| Current Liabilities | $2.0B | $1.9B | $2.0B | $2.2B | $3.2B |
| Long-Term Debt | $4.1B | $4.7B | $4.8B | $4.5B | $4.3B |
| Total Liabilities | $6.9B | $7.5B | $7.8B | $7.7B | $8.5B |
| Total Equity | $6.1B | $5.9B | $6.1B | $6.7B | $7.3B |
| Retained Earnings | $6.1B | $5.9B | $6.8B | $7.4B | $8.0B |
Cash Flow (Annual)
Last updated: Jul 11, 2026 4:43am (just now)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $883.7M | $996.0M | $1.3B | $2.1B | $1.9B |
| Capital Expenditure | -$855.7M | -$734.0M | -$743.1M | -$943.8M | -$1.0B |
| Free Cash Flow | $28.0M | $262.0M | $524.7M | $1.1B | $849.2M |
| Acquisitions (net) | -$105.3M | -$20.3M | -$3.7M | -$18.7M | -$31.9M |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | -$1.2B | -$832.9M | -$547.4M | -$670.8M | -$968.0M |
| Net Change in Cash | -$1.1B | $21.9M | $13.6M | $10.3M | $46.6M |
Analyst Estimates (Annual)
Last updated: Jul 11, 2026 4:43am (just now)| Metric | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| Revenue |
$18.5B $18.4B – $18.7B
|
$19.4B $19.2B – $19.7B
|
$20.5B $20.5B – $20.5B
|
$21.0B $20.5B – $21.3B
|
| EBITDA |
$2.6B $2.5B – $2.6B
|
$2.7B $2.6B – $2.7B
|
$2.8B $2.8B – $2.8B
|
$2.9B $2.8B – $2.9B
|
| Net Income |
$1.5B $1.5B – $1.6B
|
$1.6B $1.6B – $1.7B
|
$1.8B $1.7B – $2.0B
|
$1.9B $1.9B – $2.0B
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
Last updated: Jul 11, 2026 4:43am (just now)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +6.0% | +6.6% | +10.8% | +9.7% |
| Gross Profit Growth | +6.3% | +6.9% | +11.7% | +10.3% |
| Operating Income Growth | -26.4% | +17.1% | +43.1% | +18.6% |
| Net Income Growth | -31.9% | +6.2% | +59.1% | +30.4% |
| EBITDA Growth | -17.5% | +8.9% | +32.1% | +21.1% |
Dividend History (Last 20)
Last updated: Jul 11, 2026 4:43am (just now)| Date | Dividend | Declaration | Record | Payment |
|---|---|---|---|---|
| 2026-06-08 | $0.20 | 2026-05-27 | 2026-06-08 | 2026-06-18 |
| 2026-03-02 | $0.20 | 2026-02-12 | 2026-03-02 | 2026-03-16 |
| 2025-12-01 | $0.20 | 2025-11-18 | 2025-12-01 | 2025-12-15 |
| 2025-09-02 | $0.20 | 2025-07-16 | 2025-09-02 | 2025-09-16 |
| 2025-06-02 | $0.20 | 2025-05-14 | 2025-06-02 | 2025-06-16 |
| 2025-03-03 | $0.20 | 2025-02-12 | 2025-03-03 | 2025-03-17 |
| 2024-12-03 | $0.20 | 2024-11-20 | 2024-12-03 | 2024-12-17 |
| 2024-09-03 | $0.20 | 2024-07-18 | 2024-09-03 | 2024-09-17 |
| 2024-06-03 | $0.20 | 2024-05-15 | 2024-06-03 | 2024-06-17 |
| 2024-02-29 | $0.20 | 2024-01-17 | 2024-03-01 | 2024-03-15 |
| 2023-11-30 | $0.20 | 2023-11-15 | 2023-12-01 | 2023-12-15 |
| 2023-08-31 | $0.20 | 2023-07-20 | 2023-09-01 | 2023-09-15 |
| 2023-05-31 | $0.20 | 2023-05-17 | 2023-06-01 | 2023-06-15 |
| 2023-02-28 | $0.20 | 2023-01-18 | 2023-03-01 | 2023-03-15 |
| 2022-11-30 | $0.20 | 2022-11-16 | 2022-12-01 | 2022-12-15 |
| 2022-08-31 | $0.20 | 2022-07-20 | 2022-09-01 | 2022-09-15 |
| 2022-05-31 | $0.20 | 2022-05-18 | 2022-06-01 | 2022-06-15 |
| 2022-02-28 | $0.20 | 2022-01-28 | 2022-03-01 | 2022-03-15 |
| 2021-11-30 | $0.20 | 2021-11-17 | 2021-12-01 | 2021-12-15 |
| 2021-08-31 | $0.20 | 2021-08-19 | 2021-09-01 | 2021-09-15 |
Insider Trading (Recent)
Type codes
PPurchase
SSale
AAward / grant
MOption exercise
FIn-kind (tax)
CConversion
GGift
DReturn to issuer
All SEC Form 4 codes
Open market
- P Purchase
- Open-market or private purchase of shares.
- S Sale
- Open-market or private sale of shares.
Compensation (Rule 16b-3)
- A Award / grant
- Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
- D Return to issuer
- Securities disposed back to the company under Rule 16b-3.
- F In-kind (tax)
- Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
- I Discretionary
- Discretionary transaction under an employee plan — Rule 16b-3(f).
- M Option exercise
- Exercise or conversion of a derivative (option/RSU) into shares — exempt.
Derivatives
- C Conversion
- Conversion of a derivative security into the underlying shares.
- E Short expiration
- Expiration of a short derivative position.
- H Long expiration
- Expiration or cancellation of a long derivative position with value received.
- O OTM exercise
- Exercise of an out-of-the-money derivative.
- X ITM exercise
- Exercise of an in-the-money or at-the-money derivative.
Other exempt
- G Gift
- Bona fide gift of securities.
- L Small acquisition
- Small acquisition under Rule 16a-6.
- W Inheritance
- Acquisition or disposition by will or the laws of descent.
- Z Voting trust
- Deposit into or withdrawal from a voting trust.
Other
- J Other
- Other acquisition or disposition (explained in a Form 4 footnote).
- K Equity swap
- Transaction in an equity swap or similar instrument.
- U Tender / buyout
- Disposition via tender of shares in a change-of-control transaction.
Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-05-27 | MILLER ALAN B | J-Other | 14,163.00 | $0.00 | $0 |
| 2026-05-27 | MILLER ALAN B | J-Other | 14,163.00 | $0.00 | $0 |
| 2026-05-27 | MILLER ALAN B | J-Other | 14,163.00 | $0.00 | $0 |
| 2026-05-27 | MILLER ALAN B | J-Other | 9,418.00 | $0.00 | $0 |
| 2026-05-27 | MILLER ALAN B | J-Other | 50,990.00 | $0.00 | $0 |
| 2026-05-27 | MILLER ALAN B | J-Other | 9,418.00 | $0.00 | $0 |
| 2026-05-27 | MILLER ALAN B | J-Other | 13,963.00 | $0.00 | $0 |
| 2026-05-27 | MILLER ALAN B | J-Other | 25,495.00 | $0.00 | $0 |
| 2026-05-27 | MILLER ALAN B | J-Other | 25,495.00 | $0.00 | $0 |
| 2026-05-27 | MILLER ALAN B | J-Other | 50,990.00 | $0.00 | $0 |
| 2026-05-27 | MILLER ALAN B | J-Other | 25,495.00 | $0.00 | $0 |
| 2026-05-27 | MILLER ALAN B | J-Other | 14,163.00 | $0.00 | $0 |
| 2026-05-27 | MILLER ALAN B | J-Other | 9,418.00 | $0.00 | $0 |
| 2026-05-20 | Chen-Langenmayr Nina | A-Award | 1,217.00 | $0.00 | $0 |
| 2026-05-20 | SUSSMAN ELLIOT J MD MBA | A-Award | 1,217.00 | $0.00 | $0 |
| 2026-05-20 | McDonnell Eileen C. | A-Award | 1,217.00 | $0.00 | $0 |
| 2026-05-20 | Singer Maria Ruderman | A-Award | 1,217.00 | $0.00 | $0 |
| 2026-05-20 | Nimetz Warren J. | A-Award | 1,217.00 | $0.00 | $0 |
| 2026-03-26 | Sim Edward H | A-Award | 6,404.00 | $0.00 | $0 |
| 2026-03-26 | Peterson Matthew Jay | A-Award | 5,627.00 | $0.00 | $0 |
Narrative Economics
The story the market is telling about this stock — the intangible X-factor
(founder mythology, cult dynamics, TAM-of-imagination) that moves price beyond
what cash flows alone explain. After Shiller, Narrative Economics.
No narrative profile yet for UHS — it's generated by the pipeline (
market-narrative step).
No community reviews yet for UHS.
Be the first — hit How to Contribute, have any AI review this page, and paste its take back here.
My Notes
personal — only you see this
Sign in to save personal notes and rate your interest in this stock.
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.398 · dd6a9935 · 2026-07-10 09:48:14